ARMT1: A Potential Drug Target for Various Diseases (G79624)

Target Name: ARMT1

NCBI ID: G79624

ARMT1: A Potential Drug Target for Various Diseases

ARMT1 (Autophosphorylated RNA molecule 1) is a protein that is expressed in various tissues and cells of the human body. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues such as muscle, nerve, and heart cells.

Recent studies have identified ARMT1 as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because ARMT1 has been shown to play a role in the regulation of cellular processes that are often disrupted in these diseases, such as cell proliferation, migration, and survival.

One of the key reasons for the potential of ARMT1 as a drug target is its role in the regulation of cell proliferation. In cancer, cells often undergo rapid and uncontrolled growth, leading to the development of tumors. ARMT1 has been shown to play a role in the regulation of cell proliferation by controlling the amount of RNA produced from the DNA template. This is important because the amount of RNA produced by a cell can be used as a target for drugs that inhibit protein synthesis or can cause RNA damage.

Another potential drug target for ARMT1 is its role in the regulation of cell migration. During development, cells need to move to their final destinations in order to form tissues and organs. ARMT1 has been shown to play a role in the regulation of cell migration by controlling the movement of cellular structures such as actin filaments and microtubules. This is important because the ability of cells to migrate is critical for their development and the formation of tissues during development.

In addition to its role in cell proliferation and migration, ARMT1 has also been shown to play a role in the regulation of cell survival. In neurodegenerative diseases, such as Alzheimer's disease, cells are often lost and the brain is at risk of damage. ARMT1 has been shown to play a role in the regulation of cell survival by controlling the production of pro-inflammatory molecules that can contribute to neurodegeneration.

Finally, recent studies have suggested that ARMT1 may be a potential biomarker for the diagnosis and prognosis of various diseases. This is because the expression of ARMT1 has been shown to be altered in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. By measuring the expression of ARMT1 in tissue samples or blood samples, researchers may be able to diagnose or prognose the presence of these diseases.

In conclusion, ARMT1 is a protein that has been shown to play a role in the regulation of various cellular processes that are important for cell growth, differentiation, and survival. As a result, it is a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of ARMT1 in these diseases and to develop effective treatments.

Protein Name: Acidic Residue Methyltransferase 1

Functions: Metal-dependent phosphatase that shows phosphatase activity against several substrates, including fructose-1-phosphate and fructose-6-phosphate (By similarity). Its preference for fructose-1-phosphate, a strong glycating agent that causes DNA damage rather than a canonical yeast metabolite, suggests a damage-control function in hexose phosphate metabolism (By similarity). Has also been shown to have O-methyltransferase activity that methylates glutamate residues of target proteins to form gamma-glutamyl methyl ester residues (PubMed:25732820). Possibly methylates PCNA, suggesting it is involved in the DNA damage response (PubMed:25732820)

More Common Targets